PND13 Budget Impact Analysis and Update of a Cost Effectiveness Evaluation for Alpha (α) Polymorph Rifaximin for the Treatment of Acute Hepatic Encephalopathy
Abstract
Authors
D.P. Cardona L. Zapata M. Ceballos F. Diez I. Rico A. Zavala